AI Patent Analysis Toolkit
PatentAgility
by KellDann

Examiner Mark L. Berch

Appears inactive Last observed office action: December 2012 (160 months ago).

Examiner Mark L. Berch appears to be about average relative to their peer examiners. Their lifetime grant ratio is 54.2%, they average 1.83 office actions per granted patent, and their rejection profile is dominated by §112, with occasional §101 rejections and elevated §112 usage.

Difficulty vs AU Very Hard
Difficulty vs Group About Average
Difficulty vs TC Very Easy
Difficulty vs USPTO About Average
Average OA / Grant 1.83
Export
Word PDF

Create account to export.

Examiner Details

Observed Examiner Years
6 years (2007-2012)
Tech Center
1600 - Biotechnology and Organic
Group
1620 - Biomedicinal Chemistry

Metrics

Applications Evaluated
524
Granted Applications
284
Non-Granted Applications
240
Avg OA / Grant
1.83
Last OA Observed
December 2012 (160 months ago)
Art Units Seen
1622 , 1624
Work Groups Seen

Context Comparison

Scope Examiners Lifetime Grant Ratio Avg OA / Grant
This Examiner 1 54.2% 1.83
Art Unit 32 55.8% 1.59
Group 248 48.3% 1.76
Tech Center 1,349 39.5% 2.02
USPTO 16,116 54.8% 1.98

Grant Timeline

0.0% 25.0% 50.0% 75.0% 100.0% 2007 2008 2009 2010 2011 2012
Shaded region marks the last two observed years, where grant outcomes may lag due to recency.
Year Applications Granted Grant Rate
2007 10 7 70.0%
2008 103 69 67.0%
2009 96 48 50.0%
2010 138 63 45.7%
2011 102 52 51.0%
2012 75 45 60.0%
No observed data after 2012; examiner may have gone inactive or moved out of examining work.

284 family-cache-validated grants; 0 OA-only grant signals.

Rejection Timeline

OA # Office Actions § 101 Percentage § 102 Percentage § 103 Percentage § 112 Percentage
1 524 7.3% 2.7% 9.0% 60.5%
2 243 1.6% 2.9% 11.1% 63.0%
3 82 2.4% 3.7% 6.1% 68.3%
4 26 0.0% 3.8% 7.7% 73.1%
5 7 0.0% 14.3% 0.0% 71.4%
6 3 0.0% 0.0% 0.0% 66.7%
7 1 0.0% 0.0% 0.0% 100.0%

§ 101 Yearly Trend

0.0%
2007
5.5%
2008
6.0%
2009
4.9%
2010
5.7%
2011
2.1%
2012

Each bar shows the share of this examiner's observed office actions in that year that included a § 101 rejection.